This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Nxera Pharma receives US$3M milestone payment
Business milestone payment

Nxera Pharma receives US$3M milestone payment

Analysis based on 10 articles · First reported Feb 12, 2026 · Last updated Mar 05, 2026

Sentiment
20
Attention
2
Articles
10
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market is positively impacted by the news of a milestone payment to Nxera Pharma, indicating progress in drug development and potential future revenue. This event suggests a healthy collaboration between Nxera Pharma and Centessa Pharmaceuticals.

Pharmaceuticals Biotechnology
Event Summary

Nxera Pharma announced that Centessa Pharmaceuticals achieved an early development milestone for its investigational drug, ORX489, an orexin receptor 2 (OX2R) agonist for neuropsychiatric disorders. This achievement triggers a US$3 million payment from Centessa Pharmaceuticals to Nxera Pharma, which will be recognized as revenue in the first quarter of 2026. This milestone highlights the progress in the research collaboration between the two pharmaceutical companies.

Key Actions
90 Centessa Pharmaceuticals made a US$3 million payment Nxera Pharma
80 Centessa Pharmaceuticals achieved early development milestone for ORX489
Entities Involved
stock
Nxera Pharma
Nxera Pharma received a US$3 million milestone payment from Centessa Pharmaceuticals, which will be recognized as revenue in the first quarter of 2026. This payment is a positive financial development for Nxera Pharma.
Importance 90 Sentiment 20
stock
Centessa Pharmaceuticals
Centessa Pharmaceuticals achieved an early development milestone for its investigational drug ORX489, triggering a US$3 million payment to Nxera Pharma. This indicates progress in their drug development pipeline.
Importance 80 Sentiment 10
exch
Tokyo Stock Exchange
Nxera Pharma is listed on the Tokyo Stock Exchange, providing a trading platform for its shares.
Importance 10 Sentiment 0
Relationships
Nxera Pharma related ↔ Centessa Pharmaceuticals
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.